Skip to main content
GENOVA,Inc. logo

GENOVA,Inc. — Investor Relations & Filings

Ticker · 9341 ISIN · JP3386840007 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 37 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country JP Japan
Listing T 9341

About GENOVA,Inc.

https://genova.co.jp/

GENOVA, Inc. is a healthcare technology company that operates two primary businesses: Medical Platform and Smart Clinic. The Medical Platform business focuses on bridging the information gap between patients and providers through its core media service, "Medical Doc," which distributes accessible medical information. The Smart Clinic business supports medical institutions by providing solutions that enhance operational efficiency and productivity. This includes clinic automation tools and web marketing services designed to improve patient convenience and streamline clinic management. The company's overarching mission is to connect people with medical care to foster a healthier society.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 85% confidence The document is a Japanese ‘臨時報告書’ filed under the Financial Instruments and Exchange Act to disclose a material event (expiry of stock warrants upon a director’s resignation and related special profit recognition). This is a regulatory event report (akin to a Form 8-K or current report) that does not itself present periodic financial statements nor is it an announcement of a forthcoming report—it’s the report itself. It does not match any specific transaction or earnings release category, so it falls under the general Regulatory Filings (RNS) fallback.
2026-05-15 Japanese
2026年3月期通期決算説明資料
Investor Presentation Classification · 90% confidence The document is a standalone “決算説明資料” (financial results briefing materials) slide deck for the full year ending March 2026. It contains detailed financial results (Q4 and full-year), forward guidance for FY2027, business overview, segment analysis, growth strategy, and other investor-focused content. It is too long and richly formatted to be a simple earnings release and is clearly presented as an Investor Presentation rather than a regulatory annual report or MD&A section. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-13 Japanese
業績予想の修正に関するお知らせ
Regulatory Filings
2026-05-08 Japanese
取締役の辞任に関するお知らせ
Regulatory Filings
2026-04-30 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It serves as an officer certification regarding the accuracy of the contents of a semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 21
2025-11-13 Japanese
半期報告書－第21期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by GENOVA, Inc. under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MD&A), and business status updates for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-11-13 Japanese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.